CEPH

Cephalon (CEPH)

Cephalon (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CEPH

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2013/06/26	20 : 07	PR Newswire (US)	Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman	NASDAQ:CEPH	Cephalon (MM)
2013/06/26	20 : 07	PR Newswire (US)	Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman	NASDAQ:CEPH	Cephalon (MM)
2011/12/28	09 : 00	Zacks	Pharma & Biotech Stock Review & Outlook - Zacks Analyst Interviews	NASDAQ:CEPH	Cephalon (MM)
2011/10/21	18 : 10	Zacks	Company News for October 21, 2011 - Corporate Summary	NASDAQ:CEPH	Cephalon (MM)
2011/10/14	22 : 58	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CEPH	Cephalon (MM)
2011/10/14	22 : 34	Business Wire	Teva Completes Acquisition of Cephalon	NASDAQ:CEPH	Cephalon (MM)
2011/10/14	16 : 57	Dow Jones News	EU Clears Buy Of US Pharma Company Cephalon By Israel's Teva	NASDAQ:CEPH	Cephalon (MM)
2011/10/14	09 : 00	Zacks	COOPER TIRE (CTB) - Profit Tracks	NASDAQ:CEPH	Cephalon (MM)
2011/10/14	04 : 14	Business Wire	Teva and Cephalon Receive European Commission Approval For Acquisition	NASDAQ:CEPH	Cephalon (MM)
2011/10/12	06 : 57	PR Newswire (US)	S&P Indices Announces Change to U.S. Index	NASDAQ:CEPH	Cephalon (MM)
2011/10/12	00 : 49	Zacks	Teva a Step Closer to Cephalon - Analyst Blog	NASDAQ:CEPH	Cephalon (MM)
2011/10/11	23 : 24	Dow Jones News	Applications Given Early Antitrust Clearance	NASDAQ:CEPH	Cephalon (MM)
2011/10/11	22 : 13	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CEPH	Cephalon (MM)
2011/10/11	01 : 27	Dow Jones News	Teva To Get EU OK For Cephalon Takeover -Reuters	NASDAQ:CEPH	Cephalon (MM)
2011/10/06	20 : 29	Zacks	Teva Pharma Treads Acquisition Path - Analyst Blog	NASDAQ:CEPH	Cephalon (MM)
2011/09/30	22 : 18	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CEPH	Cephalon (MM)
2011/09/29	23 : 45	Zacks	Valeant Pharma Offer Tops Paladin's - Analyst Blog	NASDAQ:CEPH	Cephalon (MM)
2011/09/27	06 : 15	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CEPH	Cephalon (MM)
2011/09/23	02 : 00	Zacks	Pharmaceuticals Stock Outlook - Sept. 2011 - Industry Outlook	NASDAQ:CEPH	Cephalon (MM)
2011/09/22	17 : 14	Zacks	Zacks #5 Rank Additions for Thursday - Tale of the Tape	NASDAQ:CEPH	Cephalon (MM)
2011/09/16	02 : 52	Zacks	Teva to Invest More in CureTech - Analyst Blog	NASDAQ:CEPH	Cephalon (MM)
2011/09/10	06 : 09	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:CEPH	Cephalon (MM)
2011/09/07	22 : 30	PR Newswire (US)	Zacks Sell List Highlights: Molex, CenturyLink, Blue Nile and Cephalon	NASDAQ:CEPH	Cephalon (MM)
2011/09/07	09 : 00	Zacks	CENTURYTEL INC (CTL) - Profit Tracks	NASDAQ:CEPH	Cephalon (MM)
2011/09/07	09 : 00	Zacks	CENTURYTEL INC (CTL) - Profit Tracks	NASDAQ:CEPH	Cephalon (MM)
2011/09/03	00 : 00	Zacks	Valeant Pharma to Acquire Afexa - Analyst Blog	NASDAQ:CEPH	Cephalon (MM)
2011/08/23	21 : 15	Zacks	Evenly Poised Cell Therapeutics - Analyst Blog	NASDAQ:CEPH	Cephalon (MM)
2011/08/22	23 : 45	Zacks	Valeant Completes Sanitas Buy - Analyst Blog	NASDAQ:CEPH	Cephalon (MM)
2011/08/22	22 : 03	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CEPH	Cephalon (MM)
2011/08/22	21 : 34	PR Newswire (US)	Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 201...	NASDAQ:CEPH	Cephalon (MM)